Tonix Pharmaceuticals Holding (TNXP)

Tonix Pharmaceuticals, Inc. • Krele, LLC • Tonix Pharmaceuticals (Canada), Inc. • Tonix Pharma Holdings Limited • Tonix Pharma Limited • Jenner Institute LLC • Tonix R&D • Tonix Medicines, Inc. ...

IRS number

261434750

TNXP stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

8-K

Regulation FD Disclosure

Prospectus supplement for primary offering

20 Dec 24

8-K

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

17 Dec 24

S-8

Registration of securities for employees

6 Dec 24

8-K

Regulation FD Disclosure

Results of Operations and Financial Condition

12 Nov 24

8-K

Regulation FD Disclosure

8 Nov 24

8-K

Regulation FD Disclosure

4 Nov 24

Latest ownership filings

View all

SC 13G/A

ARMISTICE CAPITAL, LLC

14 Nov 24

SC 13G/A

Alyeska Investment Group, L.P.

14 Nov 24

SC 13G/A

Empery Asset Management, LP

16 Oct 24

SC 13G

L1 Capital Global Opportunities Master Fund, Ltd.

Richard Newcomb Stillwell

Financial summary

Financial statements Chart TNXP financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q2 2024

TNXP institutional ownership history Ownership history

21.5% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	12	36	-66.7%
Opened positions	4	16	-75.0%
Closed positions	28	13	+115.4%
Increased positions	1	6	-83.3%
Reduced positions	4	3	+33.3%

13F shares	Current	Prev Q	Change
Total value	52.19 mm	1.45 bn	-96.4%
Total shares	5.12 mm	12.87 mm	-60.2%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Tang Capital Partners	4.50 mm	$0.00	0.0%
L1 Capital Global Opportunities Master Fund	432.19 k	$480.00 k	NEW
CVI Investments	111.25 k	$75.00 k	0.0%
Alyeska Investment	62.50 k	$43.59 mm	NEW
Jane Street	10.95 k	$7.64 mm	-20.2%
Qube Research & Technologies	302.00	$210.00 k	+7450.0%
MS Morgan Stanley	251.00	$176.00 k	-96.8%
BAC Bank of America	28.00	$19.00 k	NEW
RY Royal Bank of Canada	4.00	$0.00	-96.5%
Global Retirement Partners	2.00	$1.00 k	-96.9%

Largest transactions	Shares	Bought/sold	Change
Sabby Management	0.00	-4.90 mm	EXIT
Rosalind Advisors	0.00	-900.90 k	EXIT
Vanguard	0.00	-530.86 k	EXIT
Armistice Capital	0.00	-489.00 k	EXIT
L1 Capital Global Opportunities Master Fund	432.19 k	+432.19 k	NEW
Geode Capital Management	0.00	-398.71 k	EXIT
Acadian Asset Management	0.00	-335.37 k	EXIT
PRU Prudential Financial	0.00	-134.80 k	EXIT
Renaissance Technologies	0.00	-124.72 k	EXIT
HCR Wealth Advisors	0.00	-100.00 k	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

TNXP insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
23 May 24	Richard H Bagger	Stock Option Common Stock	Grant	Acquire A	No	No	0.1745	104,621	18.26 k	104,621
23 May 24	Bell Margaret Smith	Stock Option Common Stock	Grant	Acquire A	No	No	0.1745	104,621	18.26 k	104,621
23 May 24	Grange David L	Stock Option Common Stock	Grant	Acquire A	No	No	0.1745	104,621	18.26 k	104,621
23 May 24	Olukotun Adeoye Y	Stock Option Common Stock	Grant	Acquire A	No	No	0.1745	104,621	18.26 k	104,621
23 May 24	Treco James	Stock Option Common Stock	Grant	Acquire A	No	No	0.1745	104,621	18.26 k	104,621